Milestone Scientific (MLSS)
(Real Time Quote from BATS)
$0.61 USD
+0.05 (9.12%)
Updated Apr 25, 2024 03:18 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Milestone Scientific, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 10 | 9 | 10 | 5 | 8 |
Cost Of Goods | 3 | 4 | 4 | 2 | 3 |
Gross Profit | 7 | 5 | 6 | 4 | 6 |
Selling & Adminstrative & Depr. & Amort Expenses | 14 | 14 | 14 | 11 | 10 |
Income After Depreciation & Amortization | -7 | -9 | -7 | -7 | -4 |
Non-Operating Income | 0 | 0 | 0 | 0 | -4 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -7 | -9 | -7 | -7 | -8 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -7 | -9 | -7 | -7 | -8 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -7 | -9 | -7 | -7 | -8 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -7 | -9 | -7 | -7 | -4 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -7 | -9 | -7 | -7 | -4 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 72.78 | 70.61 | 68.83 | 63.06 | 45.74 |
Diluted EPS Before Non-Recurring Items | -0.10 | -0.12 | -0.10 | -0.12 | -0.16 |
Diluted Net EPS (GAAP) | -0.10 | -0.12 | -0.10 | -0.12 | -0.16 |
Fiscal Year end for Milestone Scientific, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 2.26 | 2.06 | 2.91 | 2.60 |
Cost Of Goods | NA | 0.75 | 0.56 | 1.02 | 0.71 |
Gross Profit | NA | 1.51 | 1.50 | 1.89 | 1.89 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 3.49 | 3.01 | 4.17 | 3.23 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -1.98 | -1.51 | -2.28 | -1.34 |
Non-Operating Income | NA | 0.02 | 0.03 | 0.05 | 0.02 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -1.96 | -1.48 | -2.23 | -1.32 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | -0.02 | -0.01 | -0.01 | -0.01 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -1.96 | -1.48 | -2.23 | -1.32 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -1.94 | -1.47 | -2.22 | -1.31 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 73.83 | 73.73 | 72.33 | 70.67 |
Diluted EPS Before Non-Recurring Items | NA | -0.03 | -0.02 | -0.03 | -0.02 |
Diluted Net EPS (GAAP) | NA | -0.03 | -0.02 | -0.03 | -0.02 |